X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ALEMBIC PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS ALEMBIC PHARMA DR. DATSONS LABS/
ALEMBIC PHARMA
 
P/E (TTM) x -10.9 23.1 - View Chart
P/BV x 0.2 6.1 2.7% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 DR. DATSONS LABS   ALEMBIC PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ALEMBIC PHARMA
Mar-16
DR. DATSONS LABS/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs126792 15.9%   
Low Rs31443 7.0%   
Sales per share (Unadj.) Rs133.0167.0 79.6%  
Earnings per share (Unadj.) Rs0.238.2 0.4%  
Cash flow per share (Unadj.) Rs6.642.0 15.7%  
Dividends per share (Unadj.) Rs04.00 0.0%  
Dividend yield (eoy) %00.6 0.0%  
Book value per share (Unadj.) Rs128.884.9 151.7%  
Shares outstanding (eoy) m31.66188.52 16.8%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.63.7 15.9%   
Avg P/E ratio x516.116.2 3,190.5%  
P/CF ratio (eoy) x11.814.7 80.6%  
Price / Book Value ratio x0.67.3 8.4%  
Dividend payout %010.5 0.0%   
Avg Mkt Cap Rs m2,477116,383 2.1%   
No. of employees `000NANA-   
Total wages/salary Rs m564,214 1.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m4,21131,487 13.4%  
Other income Rs m7955 142.8%   
Total revenues Rs m4,28931,542 13.6%   
Gross profit Rs m56910,060 5.7%  
Depreciation Rs m204722 28.3%   
Interest Rs m43037 1,169.0%   
Profit before tax Rs m139,356 0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2-2 120.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m62,160 0.3%   
Profit after tax Rs m57,194 0.1%  
Gross profit margin %13.531.9 42.3%  
Effective tax rate %48.023.1 208.0%   
Net profit margin %0.122.8 0.5%  
BALANCE SHEET DATA
Current assets Rs m6,85215,066 45.5%   
Current liabilities Rs m6,7117,674 87.4%   
Net working cap to sales %3.323.5 14.3%  
Current ratio x1.02.0 52.0%  
Inventory Days Days16167 240.2%  
Debtors Days Days31841 783.9%  
Net fixed assets Rs m3,6738,237 44.6%   
Share capital Rs m317377 84.0%   
"Free" reserves Rs m3,76115,416 24.4%   
Net worth Rs m4,07816,005 25.5%   
Long term debt Rs m1,6710-   
Total assets Rs m12,63324,594 51.4%  
Interest coverage x1.0255.2 0.4%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.31.3 26.0%   
Return on assets %3.429.4 11.7%  
Return on equity %0.144.9 0.3%  
Return on capital %7.758.7 13.1%  
Exports to sales %22.955.7 41.1%   
Imports to sales %14.310.4 137.1%   
Exports (fob) Rs m96417,551 5.5%   
Imports (cif) Rs m6023,283 18.3%   
Fx inflow Rs m96417,811 5.4%   
Fx outflow Rs m6075,318 11.4%   
Net fx Rs m35712,493 2.9%   
CASH FLOW
From Operations Rs m1,3459,304 14.5%  
From Investments Rs m-2,256-3,105 72.6%  
From Financial Activity Rs m-1,200-1,959 61.2%  
Net Cashflow Rs m-2,1114,240 -49.8%  

Share Holding

Indian Promoters % 4.5 74.1 6.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 2.9 -  
FIIs % 1.4 9.1 14.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 13.9 677.0%  
Shareholders   20,807 49,328 42.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   FRESENIUS KABI ONCO.  AJANTA PHARMA  UNICHEM LAB  NATCO PHARMA  ELDER PHARMA  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Lower; Tata Steel & Vedanta Top Losers(Closing)

Indian share markets erased early gains to end lower today, as the opposition parties tabled a no-confidence motion against Prime Minister Narendra Modi's government.

Related Views on News

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

More Views on News

Most Popular

How to Avoid a 90% Loss Suffered by This Super Investor(The 5 Minute Wrapup)

Jul 12, 2018

Blindly following super investors is a dangerous game to play. Here's how you can avoid such mistakes.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

New Fund Offer - ICICI Prudential Pharma Healthcare and Diagnostics Fund - Should You Invest?(Outside View)

Jul 6, 2018

ICICI AMC launches an open -ended equity fund following Pharma, Healthcare, Diagnostic and allied theme.

When Disappointment Panda is Around. Buy Quality Stock like This!(Chart Of The Day)

Jul 6, 2018

Buy Companies that can fight all kinds of Pandas and Bears in the long run.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS